188 related articles for article (PubMed ID: 12946271)
1. Improvement in hydrolytic antibody activity by change in haptenic structure from phosphate to phosphonate with retention of a common leaving-group determinant: evidence for the 'flexibility' hypothesis.
Gul S; Sonkaria S; Pinitglang S; Florez-Alvarez J; Hussain S; Thomas EW; Ostler EL; Gallacher G; Resmini M; Brocklehurst K
Biochem J; 2003 Dec; 376(Pt 3):813-21. PubMed ID: 12946271
[TBL] [Abstract][Full Text] [Related]
2. Evidence for 'lock and key' character in an anti-phosphonate hydrolytic antibody catalytic site augmented by non-reaction centre recognition: variation in substrate selectivity between an anti-phosphonate antibody, an anti-phosphate antibody and two hydrolytic enzymes.
Sonkaria S; Boucher G; Flórez-Olvarez J; Said B; Hussain S; Ostler EL; Gul S; Thomas EW; Resmini M; Gallacher G; Brocklehurst K
Biochem J; 2004 Jul; 381(Pt 1):125-30. PubMed ID: 15053743
[TBL] [Abstract][Full Text] [Related]
3. Efficient and selective p-nitrophenyl-ester-hydrolyzing antibodies elicited by a p-nitrobenzyl phosphonate hapten.
Tawfik DS; Lindner AB; Chap R; Eshhar Z; Green BS
Eur J Biochem; 1997 Mar; 244(2):619-26. PubMed ID: 9119032
[TBL] [Abstract][Full Text] [Related]
4. Mechanistic analysis of the phosphonate transition-state analogue-derived catalytic and non-catalytic antibody.
Nishi Y; Yamamoto N; Shimazaki K; Takahashi-Ando N; Kakinuma H; Jialin S; Ruzheinikov SN; Muranova TA; Rice DW; Kajihara Y
J Biochem; 2007 Oct; 142(4):421-33. PubMed ID: 17981825
[TBL] [Abstract][Full Text] [Related]
5. Thermodynamic and structural basis for transition-state stabilization in antibody-catalyzed hydrolysis.
Oda M; Ito N; Tsumuraya T; Suzuki K; Sakakura M; Fujii I
J Mol Biol; 2007 May; 369(1):198-209. PubMed ID: 17428500
[TBL] [Abstract][Full Text] [Related]
6. A structural basis for transition-state stabilization in antibody-catalyzed hydrolysis: crystal structures of an abzyme at 1. 8 A resolution.
Kristensen O; Vassylyev DG; Tanaka F; Morikawa K; Fujii I
J Mol Biol; 1998 Aug; 281(3):501-11. PubMed ID: 9698565
[TBL] [Abstract][Full Text] [Related]
7. Toward bifunctional antibody catalysis.
Kikuchi K; Hannak RB; Guo MJ; Kirby AJ; Hilvert D
Bioorg Med Chem; 2006 Sep; 14(18):6189-96. PubMed ID: 16782349
[TBL] [Abstract][Full Text] [Related]
8. Induction of covalent binding antibodies.
Armentano F; Knight T; Makker S; Tramontano A
Immunol Lett; 2006 Feb; 103(1):51-7. PubMed ID: 16297987
[TBL] [Abstract][Full Text] [Related]
9. Transition state docking: a probe for noncovalent catalysis in biological systems. Application to antibody-catalyzed ester hydrolysis.
Tantillo DJ; Houk KN
J Comput Chem; 2002 Jan; 23(1):84-95. PubMed ID: 11913392
[TBL] [Abstract][Full Text] [Related]
10. An investigation of antibody acyl hydrolysis catalysis using a large set of related haptens.
Odenbaugh AL; Helms ED; Iverson BL
Bioorg Med Chem; 2000 Feb; 8(2):413-26. PubMed ID: 10722164
[TBL] [Abstract][Full Text] [Related]
11. Directed evolution governed by controlling the molecular recognition between an abzyme and its haptenic transition-state analog.
Takahashi-Ando N; Kakinuma H; Fujii I; Nishi Y
J Immunol Methods; 2004 Nov; 294(1-2):1-14. PubMed ID: 15604011
[TBL] [Abstract][Full Text] [Related]
12. Mutational, structural, and kinetic evidence for a dissociative mechanism in the GDP-mannose mannosyl hydrolase reaction.
Xia Z; Azurmendi HF; Lairson LL; Withers SG; Gabelli SB; Bianchet MA; Amzel LM; Mildvan AS
Biochemistry; 2005 Jun; 44(25):8989-97. PubMed ID: 15966723
[TBL] [Abstract][Full Text] [Related]
13. Resolution of chiral phosphate, phosphonate, and phosphinate esters by an enantioselective enzyme library.
Nowlan C; Li Y; Hermann JC; Evans T; Carpenter J; Ghanem E; Shoichet BK; Raushel FM
J Am Chem Soc; 2006 Dec; 128(49):15892-902. PubMed ID: 17147402
[TBL] [Abstract][Full Text] [Related]
14. Crossreactivity, efficiency and catalytic specificity of an esterase-like antibody.
Gigant B; Charbonnier JB; Eshhar Z; Green BS; Knossow M
J Mol Biol; 1998 Dec; 284(3):741-50. PubMed ID: 9826512
[TBL] [Abstract][Full Text] [Related]
15. Large rate accelerations in antibody catalysis by strategic use of haptenic charge.
Thorn SN; Daniels RG; Auditor MT; Hilvert D
Nature; 1995 Jan; 373(6511):228-30. PubMed ID: 7816136
[TBL] [Abstract][Full Text] [Related]
16. Catalytic antibody activity elicited by active immunisation. Evidence for natural variation involving preferential stabilization of the transition state.
Gallacher G; Jackson CS; Searcey M; Goel R; Mellor GW; Smith CZ; Brocklehurst K
Eur J Biochem; 1993 May; 214(1):197-207. PubMed ID: 8508792
[TBL] [Abstract][Full Text] [Related]
17. Catalytic antibodies that hydrolyze (-)-cocaine obtained by a high-throughput procedure.
Cashman JR; Berkman CE; Underiner GE
J Pharmacol Exp Ther; 2000 Jun; 293(3):952-61. PubMed ID: 10869397
[TBL] [Abstract][Full Text] [Related]
18. A comparison of flexible and constrained haptens in eliciting antibody catalysts for paraoxon hydrolysis.
Spivak DA; Hoffman TZ; Moore AH; Taylor MJ; Janda KD
Bioorg Med Chem; 1999 Jun; 7(6):1145-50. PubMed ID: 10428386
[TBL] [Abstract][Full Text] [Related]
19. Evidence that the mechanism of antibody-catalysed hydrolysis of arylcarbamates can be determined by the structure of the immunogen used to elicit the catalytic antibody.
Boucher G; Said B; Ostler EL; Resmini M; Brocklehurst K; Gallacher G
Biochem J; 2007 Feb; 401(3):721-6. PubMed ID: 17020536
[TBL] [Abstract][Full Text] [Related]
20. Substrate-assisted antibody catalysis.
Deng S; Bharat N; de Prada P; Landry DW
Org Biomol Chem; 2004 Feb; 2(3):288-90. PubMed ID: 14747854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
